121 related articles for article (PubMed ID: 37987687)
41. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
Binkley MS; Rauf MS; Milgrom SA; Pinnix CC; Tsang R; Dickinson M; Ng AK; Roberts KB; Gao S; Balogh A; Ricardi U; Levis M; Casulo C; Stolten M; Specht L; Plastaras JP; Wright C; Kelsey CR; Brady JL; Mikhaeel NG; Hoppe BS; Terezakis SA; Picardi M; Della Pepa R; Kirova Y; Akhtar S; Maghfoor I; Koenig JL; Jackson C; Song E; Sehgal S; Advani RH; Natkunam Y; Constine LS; Eich HT; Wirth A; Hoppe RT
Blood; 2020 Jun; 135(26):2365-2374. PubMed ID: 32211877
[TBL] [Abstract][Full Text] [Related]
42. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
Mac Manus MP; Rainer Bowie CA; Hoppe RT
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):365-71. PubMed ID: 9788417
[TBL] [Abstract][Full Text] [Related]
43. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
44. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
45. Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).
Chen B; Zhu SY; Shi M; Su H; Wang Y; He X; Xu LM; Yuan ZY; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Wu T; Qi SN; Yang Y; Liu X; Li YX
Cancer Med; 2018 Dec; 7(12):5952-5961. PubMed ID: 30358175
[TBL] [Abstract][Full Text] [Related]
46. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
[TBL] [Abstract][Full Text] [Related]
47. Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
Wang X; Lu X; Chen J; Yi H; Lan Q
BMC Surg; 2023 Oct; 23(1):299. PubMed ID: 37789291
[TBL] [Abstract][Full Text] [Related]
48. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.
Andraos TY; Ayoub Z; Nastoupil LJ; Milgrom SA; Pinnix CC; Ng SP; Gunther JR; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Dabaja BS
Leuk Lymphoma; 2019 Dec; 60(13):3258-3265. PubMed ID: 31234671
[TBL] [Abstract][Full Text] [Related]
49. How to manage early-stage follicular lymphoma.
Cencini E; Fabbri A; Mecacci B; Bocchia M
Expert Rev Hematol; 2020 Oct; 13(10):1093-1105. PubMed ID: 32869685
[TBL] [Abstract][Full Text] [Related]
50. Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?
Bentur OS; Gurion R; Gafter-Gvili A; Gatt M; Shvidel L; Horowitz NA; Ram R; Herishanu Y; Sarid N; Paltiel O; Ganzel C; Kreiniz N; Dally N; Gutwein O; Raanani P; Avivi I; Perry C
Leuk Lymphoma; 2018 May; 59(5):1163-1171. PubMed ID: 28901817
[TBL] [Abstract][Full Text] [Related]
51. Gastrointestinal follicular lymphoma: using primary site as a predictor of survival.
Chouhan J; Batra S; Gupta R; Guha S
Cancer Med; 2016 Oct; 5(10):2669-2677. PubMed ID: 27696758
[TBL] [Abstract][Full Text] [Related]
52. Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Tobin JWD; Rule G; Colvin K; Calvente L; Hodgson D; Bell S; Dunduru C; Gallo J; Tsang ES; Tan X; Wong J; Pearce J; Campbell R; Tneh S; Shorten S; Ng M; Cochrane T; Tam CS; Abro E; Hawkes E; Hodges G; Kansara R; Talaulikar D; Gilbertson M; Johnston AM; Savage KJ; Villa D; Morris K; Ratnasingam S; Janowski W; Kridel R; Cheah CY; MacManus M; Matigian N; Mollee P; Gandhi MK; Hapgood G
Blood Adv; 2019 Oct; 3(19):2804-2811. PubMed ID: 31570492
[TBL] [Abstract][Full Text] [Related]
53. The survival impact of adjuvant radiotherapy and chemotherapy in patients with non-endometrioid endometrial carcinomas: a PSM-IPTW analysis based on SEER database.
Hao Z; Yu Y
BMC Womens Health; 2023 May; 23(1):278. PubMed ID: 37210506
[TBL] [Abstract][Full Text] [Related]
54. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
[TBL] [Abstract][Full Text] [Related]
55. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis.
Li J; Jia Y; Cheng Y; Wang J
Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890
[TBL] [Abstract][Full Text] [Related]
56. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
57. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
[No Abstract] [Full Text] [Related]
58. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy.
Campbell BA; Voss N; Woods R; Gascoyne RD; Morris J; Pickles T; Connors JM; Savage KJ
Cancer; 2010 Aug; 116(16):3797-806. PubMed ID: 20564082
[TBL] [Abstract][Full Text] [Related]
59. The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment.
Naik A; Gooley T; Loeb K; Soma L; Smith SD; Gopal A; Naresh KN
Br J Haematol; 2022 Dec; 199(5):696-706. PubMed ID: 35973829
[TBL] [Abstract][Full Text] [Related]
60. Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma.
Kwong YL; Kim SJ; Tse E; Oh SY; Kwak JY; Eom HS; Do YR; Mun YC; Lee SR; Shin HJ; Suh C; Chuang SS; Lee YS; Lim ST; Izutsu K; Suzuki R; Relander T; d'Amore F; Schmitz N; Jaccard A; Kim WS
Ann Oncol; 2018 Jan; 29(1):256-263. PubMed ID: 29077846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
